GSK vs TONX · P/E 13, $103.31B cap vs rev $18.0M
GlaxoSmithKline PLC ADR (GSK) versus TON Strategy Co (TONX) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
TON Strategy Co (TONX) is a software - application company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported TONX revenue for 2026-06-30 was $18.0M. Net income was -$14.3M. TONX currently screens at market cap $198.4M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TONX currently screens at market cap $198.4M.
Not investment advice. Open the GSK and TONX stock pages for the full models.
Not investment advice.